This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.
Approval for the stan s31 fetal heart monitor. The device is indicated as an adjunct to fetal heart rate monitoring to determine whether obstetrical intervention is warranted when there is increased risk of developing metabolic acidosis. The device is intended for use in patients with: 1) planned vaginal delivery; 2) >36 completed weeks gestation; 3) singleton fetus; 4) vertex presentation; and 5) ruptured amniotic membranes.
| Device | STAN S31 FETAL HEART MONITOR |
| Generic Name | Analyzer, Data, Obstetric |
| Applicant | NEOVENTA MEDICAL AB |
| Date Received | 2002-01-02 |
| Decision Date | 2005-11-01 |
| Notice Date | 2006-01-09 |
| PMA | P020001 |
| Supplement | S |
| Product Code | HEO |
| Docket Number | 06M-0009 |
| Advisory Committee | Obstetrics/Gynecology |
| Expedited Review | No |
| Combination Product | No |
| Applicant Address | NEOVENTA MEDICAL AB norra Agatan 32 se-431 35 molndal |
| Summary: | Summary of Safety and Effectiveness |
| Labeling: | Labeling |
| Approval Order: | Approval Order |
| Supplement Number | Date | Supplement Type |
|---|---|---|
| P020001 | Original Filing | |
| S009 | 2011-09-21 | Real-time Process |
| S008 | 2011-07-07 | 30-day Notice |
| S007 | 2009-07-23 | Normal 180 Day Track |
| S006 | 2009-09-11 | Real-time Process |
| S005 | 2008-02-04 | Real-time Process |
| S004 | 2007-10-11 | Normal 180 Day Track |
| S003 | ||
| S002 | 2007-08-13 | Real-time Process |
| S001 | 2007-06-04 | 30-day Notice |